Evidence map›Paper›PMID 40100512›Full record

ArticleInternational ophthalmology2025

Evaluation of anterior segment parameters by topography and optical biometry according to the localization of pseudoexfoliation material.

Furkan Oz, Ali Mesen, Selma Mesen

Abstract read
PubMed Publisher
In one paragraph

Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Furkan OzOphthalmology Department Şahinbey, Gaziantep City Hospital, 27470, Gaziantep, Turkey.ORCID https://orcid.org/0000-0001-5783-5760
Ali MesenOphthalmology Department Onikisubat, Sutcu Imam University Health Practice and Research Hospital, 46040, Kahramanmaras, Turkey. dralimesen@gmail.com.ORCID https://orcid.org/0000-0002-0361-9066
Selma MesenOphthalmology Department Onikisubat, Sutcu Imam University Health Practice and Research Hospital, 46040, Kahramanmaras, Turkey.ORCID https://orcid.org/0000-0002-5556-8635

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to classify the anterior segment parameters in cases of pseudoexfoliation (PEX) according to the region where the PEX material was observed. MATERIALS AND

methodsA total of 90 eyes of 90 patients were included in this prospective study according to the localization of PEX accumulation: 33 on the lens (Group 1), 46 on the lens and at the pupillary edge (Group 2), 11 on the lens, at the pupillary edge, and at the iridocorneal angle (Group 3). Pre-dilation (pre-D) and post-dilation (post-D) corneal topography and optical biometry measurements were performed on the patients.

resultsPupil diameter (PD) and anterior chamber depth (ACD) increased in post-D compared to pre-D in all three groups (p < 0.05). Group 3 showed wider pre-D PD compared to Groups 1 and 2 (p = 0.02). Iridocorneal angle (ICA) width increased in Group 1 post-D compared to pre-D (p < 0.05). Intraocular pressure was lower in Group 1 compared to Groups 2 and 3 (p < 0.05).

conclusionPD, ACD, and ICA may vary in PEX cases, depending on the localization of PEX material accumulation. The extent of PEX in the anterior chamber may have an impact on IOP values. Optical biometry and corneal topography devices are useful, rapid, and non-invasive methods for detecting anterior segment morphological differences in PEX cases.

Indexed as

Anterior Eye SegmentBiometryCorneal TopographyExfoliation SyndromeAgedAged, 80 and overFemaleHumansIntraocular PressureMaleMiddle AgedProspective StudiesAnterior segmentLenstarPentacamPseudoexfoliationScheimpflug topography

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.